Iris M. Otani, M.D.

85% fewer Medicare Part D claims than the average allergy & immunology (internal medicine) physician in 2024

120 Medicare Part D claims for 35 beneficiaries, against an average of 789 among the 429 providers of this specialty who prescribed in Part D. Brand-name drugs were 42% of claims.

Most prescribed

1. Azelastine Hcl22 claims
2. Ipratropium Bromide11 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 74.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $2,300.00

2 payments; by number, the most common kind was honoraria; the largest payer was Genzyme Corporation. The 321 providers of this specialty with any payment received $7,456.30 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 3 group practices

1. Regents OF The University OF CaliforniaSan Francisco, CA
2. Ucsf Medical Group Business ServicesSan Francisco, CA
3. University OF California San FranciscoSan Francisco, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).